- 2014 Conference
Distinguished Lecture and Tribute to Dr. Joep Lange, by Eric van Gorp
Dr. Joep Lange
Joep Lange was the Professor of Medicine, Head of the Department of Global Health, at the Academic Medical Center (AMC), University of Amsterdam, Executive Scientific Director of the Amsterdam Institute for Global Health and Development (AIGHD), and Chair of the Steering Committee AIGHD.
Joep Lange had been involved in HIV research and treatment since 1983. He was the architect and principal investigator of several pivotal trials on antiretroviral therapy and on the prevention of mother-to-child transmission of HIV in both the developed and developing world.
In addition to various positions at the AMC, he was Chief of Clinical Research and Drug Development at the Global Programme on AIDS of the World Health Organization in Geneva from 1992 to 1995. From 2002–2004 he was President of the International AIDS Society. He served on numerous advisory boards for both private and public sector organisations, including the Strategic and Technical Advisory Committee of the WHO HIV Department, the External Advisory Committee of the US HIV Vaccine Trials Network and the International Advisory Board of the Institute for Global Health of Imperial College. He also served as the Chairman of the PharmAccess Foundation (which he founded) and as Scientific Advisor to the Board of the Health Insurance Fund Foundation, which pioneers mechanisms of sustainable financing of health care in resource-poor settings. He was a member of the Supervisory Board of KNCV Tuberculosis Foundation. Joep Lange founded and was Editor-in-Chief of the Journal Antiviral Therapy and served on several other editorial boards of scientific journals. He published more than 350 papers in peer-reviewed journals and guided more than 30 PhD students. In 2007 he was awarded the Eijkman medal for his achievements in Tropical Medicine and International Health.
The workshop organizers and Caribbean HIV community mourn the loss of Dr. Joep Lange who died on July 17th 2014 in the Malaysian Airlines tragedy over Ukraine. We offer our condolences to the family and friends of Dr. Lange, while extending our gratitude to Eric van Gorp for delivering this tribute to Dr. Lange and his life's work.
For more information about Dr. Lange and previous Distinguished Lecturers, click here.
More About this Year's Theme
The theme "Prevention benefits of antiretroviral therapy in Caribbean HIV patients: the central role of patient engagement in the continuum of care" has been selected to drill down into detail what constitutes a successful treatment and prevention program. It begins with an accessible HIV test capable of reaching vulnerable populations, which faces the perennial challenge how to destigmatize the disease in our small island settings while extending the necessary support to assist diagnosis and recruitment of positive persons into care.
The next step in the continuum is to retain and monitor patients during care to stage antiretroviral therapy and treat coinfections. And finally, possibly the hardest step, is to provide the necessary social support to counsel effective drug adherence in our patients, thereby driving down HIV viral load and securing the full prevention benefits of antiretroviral therapy by cutting back disease transmission in our communities. It is appropriate that our CCAS distinguished speaker, Joep Lange, is editor of the journal "Antiviral Therapy" and he anchors a CME accredited curriculum that aims to strengthen all aspects of the continuum of care.
This serves to announce The 3rd Joint Meeting of the CHART-CCAS-CMLF and the 11th CCAS HIV International Workshop to be held in St. Maarten from the 24th - 28th of August 2014. The theme of this year's meeting is: Prevention benefits of antiretroviral therapy in Caribbean HIV patients: the central role of patient engagement in the continuum of care.
For more information about the Conference, please vist the 2014 Conference Page.
To register for the meeting, complete the registration form.